MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

NCT05114213 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Low accrual, close out in November 2025

Conditions

Pancreatic Cancer

Interventions

RADIATION: SBRT
DRUG: SOC chemotherapy

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]
[object Object]